Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 14,300

• Price / Volume Information    Yesterday's Closing Price: $23.63 Daily Weekly Monthly 20 Day Moving Average: 1,820,490 shares Shares Outstanding: 95.10 (millions) Market Capitalization: $2,247.21 (millions) Beta: 1.93 52 Week High: $24.84 52 Week Low: $8.55 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 18.03% 19.28% 12 Week 23.85% 20.82% Year To Date 36.99% 23.87%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27713 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Anshul Thakral - Chief Executive Officer;President Peter M. Neupert - Chairman of the Board Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/29/26 Share - Related Items Shares Outstanding: 95.10 Most Recent Split Date: (:1) Beta: 1.93 Market Capitalization: $2,247.21 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.86 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 48.60% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/29/26

• Fundamental Ratios P/E Current FY Estimate: 27.60 Trailing 12 Months: 39.38 PEG Ratio: 0.57 Price Ratios Price/Book: 4.29 Price/Cash Flow: 2.38 Price / Sales: 0.84 EPS Growth vs. Year Ago Period: 21.05% vs. Previous Quarter: 43.75% Sales Growth vs. Year Ago Period: -4.52% vs. Previous Quarter: 6.55% ROE 09/30/26 - - 06/30/26 - 10.72 03/31/26 - 9.51 ROA 09/30/26 - - 06/30/26 - 2.17 03/31/26 - 1.96 Current Ratio 09/30/26 - - 06/30/26 - 0.96 03/31/26 - 0.95 Quick Ratio 09/30/26 - - 06/30/26 - 0.96 03/31/26 - 0.95 Operating Margin 09/30/26 - - 06/30/26 - 2.20 03/31/26 - 1.98 Net Margin 09/30/26 - - 06/30/26 - -3.18 03/31/26 - -16.50 Pre-Tax Margin 09/30/26 - - 06/30/26 - -2.91 03/31/26 - -16.51 Book Value 09/30/26 - - 06/30/26 - 5.51 03/31/26 - 5.56 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 1.98 03/31/26 - 1.98 Debt-to-Capital 09/30/26 - - 06/30/26 - 66.43 03/31/26 - 66.47

Powered by Zacks Investment Research ©